[1] S. Chatterjee, K. Khunti, M.J. Davies, Type 2 diabetes, Lancet 389(10085) (2017) 2239-2251.
[2] R.J. McCrimmon, C.M. Ryan, B.M. Frier, Diabetes and cognitive dysfunction, Lancet 379(9833) (2012) 2291-9.
[3] C. Moucheraud, C. Lenz, M. Latkovic, V.J. Wirtz, The costs of diabetes treatment in low- and middle-income countries: a systematic review, BMJ Glob Health 4(1) (2019) e001258.
[4] H.G. Kim, Cognitive dysfunctions in individuals with diabetes mellitus, Yeungnam Univ J Med 36(3) (2019) 183-191.
[5] C.T. Kodl, E.R. Seaquist, Cognitive dysfunction and diabetes mellitus, Endocr Rev 29(4) (2008) 494-511.
[6] S.J. Dixon, K.M. Lemberg, M.R. Lamprecht, R. Skouta, E.M. Zaitsev, C.E. Gleason, D.N. Patel, A.J. Bauer, A.M. Cantley, W.S. Yang, B. Morrison, 3rd, B.R. Stockwell, Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell 149(5) (2012) 1060-72.
[7] B.R. Stockwell, J.P. Friedmann Angeli, H. Bayir, A.I. Bush, M. Conrad, S.J. Dixon, S. Fulda, S. Gascon, S.K. Hatzios, V.E. Kagan, K. Noel, X. Jiang, A. Linkermann, M.E. Murphy, M. Overholtzer, A. Oyagi, G.C. Pagnussat, J. Park, Q. Ran, C.S. Rosenfeld, K. Salnikow, D. Tang, F.M. Torti, S.V. Torti, S. Toyokuni, K.A. Woerpel, D.D. Zhang, Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease, Cell 171(2) (2017) 273-285.
[8] R.P. Abrams, W.L. Carroll, K.A. Woerpel, Five-Membered Ring Peroxide Selectively Initiates Ferroptosis in Cancer Cells, ACS chemical biology 11(5) (2016) 1305-12.
[9] R. Sheelakumari, C. Kesavadas, T. Varghese, R.M. Sreedharan, B. Thomas, J. Verghese, P.S. Mathuranath, Assessment of Iron Deposition in the Brain in Frontotemporal Dementia and Its Correlation with Behavioral Traits, AJNR. American journal of neuroradiology 38(10) (2017) 1953-1958.
[10] A.A. Belaidi, A.I. Bush, Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics, J Neurochem 139 Suppl 1 (2016) 179-197.
[11] L. Magtanong, S.J. Dixon, Ferroptosis and Brain Injury, Developmental neuroscience (2019) 1-14.
[12] G. Morris, M. Berk, A.F. Carvalho, M. Maes, A.J. Walker, B.K. Puri, Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases, Behavioural brain research 341 (2018) 154-175.
[13] N. Yan, J. Zhang, Iron Metabolism, Ferroptosis, and the Links With Alzheimer's Disease, Front Neurosci 13 (2019) 1443.
[14] Y. Mi, X. Gao, H. Xu, Y. Cui, Y. Zhang, X. Gou, The Emerging Roles of Ferroptosis in Huntington's Disease, Neuromolecular Med 21(2) (2019) 110-119.
[15] S. Ayton, P. Lei, D.J. Hare, J.A. Duce, J.L. George, P.A. Adlard, C. McLean, J.T. Rogers, R.A. Cherny, D.I. Finkelstein, A.I. Bush, Parkinson's disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein, J Neurosci 35(8) (2015) 3591-7.
[16] Y. Ohyagi, K. Miyoshi, N. Nakamura, Therapeutic Strategies for Alzheimer's Disease in the View of Diabetes Mellitus, Adv Exp Med Biol 1128 (2019) 227-248.
[17] G.J. Biessels, L.P. van der Heide, A. Kamal, R.L. Bleys, W.H. Gispen, Ageing and diabetes: implications for brain function, European journal of pharmacology 441(1-2) (2002) 1-14.
[18] C.M. Embury, A.I. Wiesman, A.L. Proskovec, E. Heinrichs-Graham, T.J. McDermott, G.H. Lord, K.L. Brau, A.T. Drincic, C.V. Desouza, T.W. Wilson, Altered Brain Dynamics in Patients With Type 1 Diabetes During Working Memory Processing, Diabetes 67(6) (2018) 1140-1148.
[19] G.J. Biessels, I.J. Deary, C.M. Ryan, Cognition and diabetes: a lifespan perspective, The Lancet. Neurology 7(2) (2008) 184-90.
[20] S.E. Wenzel, Y.Y. Tyurina, J. Zhao, C.M. St Croix, H.H. Dar, G. Mao, V.A. Tyurin, T.S. Anthonymuthu, A.A. Kapralov, A.A. Amoscato, K. Mikulska-Ruminska, I.H. Shrivastava, E.M. Kenny, Q. Yang, J.C. Rosenbaum, L.J. Sparvero, D.R. Emlet, X. Wen, Y. Minami, F. Qu, S.C. Watkins, T.R. Holman, A.P. VanDemark, J.A. Kellum, I. Bahar, H. Bayir, V.E. Kagan, PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals, Cell 171(3) (2017) 628-641.e26.
[21] J.Y. Cao, S.J. Dixon, Mechanisms of ferroptosis, Cell Mol Life Sci 73(11-12) (2016) 2195-209.
[22] J.P.F. Angeli, R. Shah, D.A. Pratt, M. Conrad, Ferroptosis Inhibition: Mechanisms and Opportunities, Trends Pharmacol Sci 38(5) (2017) 489-498.
[23] R.P. Bazinet, S. Laye, Polyunsaturated fatty acids and their metabolites in brain function and disease, Nat Rev Neurosci 15(12) (2014) 771-85.
[24] A. Weiland, Y. Wang, W. Wu, X. Lan, X. Han, Q. Li, J. Wang, Ferroptosis and Its Role in Diverse Brain Diseases, Mol Neurobiol 56(7) (2019) 4880-4893.
[25] K.V. Haak, A.F. Marquand, C.F. Beckmann, Connectopic mapping with resting-state fMRI, Neuroimage 170 (2018) 83-94.
[26] Y.F. Zang, Y. He, C.Z. Zhu, Q.J. Cao, M.Q. Sui, M. Liang, L.X. Tian, T.Z. Jiang, Y.F. Wang, Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI, Brain Dev 29(2) (2007) 83-91.
[27] V. Kiviniemi, J.H. Kantola, J. Jauhiainen, O. Tervonen, Comparison of methods for detecting nondeterministic BOLD fluctuation in fMRI, Magn Reson Imaging 22(2) (2004) 197-203.
[28] L.X. Yuan, J.B. Wang, N. Zhao, Y.Y. Li, Y. Ma, D.Q. Liu, H.J. He, J.H. Zhong, Y.F. Zang, Intra- and Inter-scanner Reliability of Scaled Subprofile Model of Principal Component Analysis on ALFF in Resting-State fMRI Under Eyes Open and Closed Conditions, Frontiers in neuroscience 12 (2018) 311.
[29] P. Wang, J. Yang, Z. Yin, J. Duan, R. Zhang, J. Sun, Y. Xu, L. Liu, X. Chen, H. Li, J. Kang, Y. Zhu, X. Deng, M. Chang, S. Wei, Y. Zhou, X. Jiang, F. Wang, Y. Tang, Amplitude of low-frequency fluctuation (ALFF) may be associated with cognitive impairment in schizophrenia: a correlation study, BMC Psychiatry 19(1) (2019) 30.
[30] Q. Yang, L. Zhou, C. Liu, D. Liu, Y. Zhang, C. Li, Y. Shang, X. Wei, C. Li, J. Wang, Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study, Brain imaging and behavior 12(5) (2018) 1479-1487.
[31] K.M. Hasan, I.S. Walimuni, L.A. Kramer, P.A. Narayana, Human brain iron mapping using atlas-based T2 relaxometry, Magn Reson Med 67(3) (2012) 731-739.
[32] E.M. Haacke, N.Y.C. Cheng, M.J. House, Q. Liu, J. Neelavalli, R.J. Ogg, A. Khan, M. Ayaz, W. Kirsch, A. Obenaus, Imaging iron stores in the brain using magnetic resonance imaging, Magnetic resonance imaging 23(1) (2005) 1-25.
[33] S. Doll, M. Conrad, Iron and ferroptosis: A still ill-defined liaison, IUBMB Life 69(6) (2017) 423-434.
[34] A. Ayala, M.F. Munoz, S. Arguelles, Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal, Oxid Med Cell Longev 2014 (2014) 360438.
[35] N. Zarkovic, A. Cipak, M. Jaganjac, S. Borovic, K. Zarkovic, Pathophysiological relevance of aldehydic protein modifications, J Proteomics 92 (2013) 239-47.
[36] S.M. Chiroma, M.T. Hidayat Baharuldin, C.N. Mat Taib, Z. Amom, S. Jagadeesan, M.I. Adenan, M.A. Mohd Moklas, Protective effect of Centella asiatica against D-galactose and aluminium chloride induced rats: Behavioral and ultrastructural approaches, Biomed Pharmacother 109 (2019) 853-864.
[37] M. Theurl, D. Song, E. Clark, J. Sterling, S. Grieco, S. Altamura, B. Galy, M. Hentze, M.U. Muckenthaler, J.L. Dunaief, Mice with hepcidin-resistant ferroportin accumulate iron in the retina, FASEB journal : official publication of the Federation of American Societies for Experimental Biology 30(2) (2016) 813-23.
[38] S. Lakhal-Littleton, M. Wolna, C.A. Carr, J.J. Miller, H.C. Christian, V. Ball, A. Santos, R. Diaz, D. Biggs, R. Stillion, P. Holdship, F. Larner, D.J. Tyler, K. Clarke, B. Davies, P.A. Robbins, Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function, Proceedings of the National Academy of Sciences of the United States of America 112(10) (2015) 3164-9.
[39] N. Geng, B.J. Shi, S.L. Li, Z.Y. Zhong, Y.C. Li, W.L. Xua, H. Zhou, J.H. Cai, Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells, European review for medical and pharmacological sciences 22(12) (2018) 3826-3836.
[40] F. Du, Z.M. Qian, Q. Luo, W.H. Yung, Y. Ke, Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats, Molecular neurobiology 52(1) (2015) 101-14.
[41] R.C. McCarthy, Y.H. Park, D.J. Kosman, sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin, EMBO reports 15(7) (2014) 809-15.
[42] A.A. Raha, R.A. Vaishnav, R.P. Friedland, A. Bomford, R. Raha-Chowdhury, The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease, Acta neuropathologica communications 1 (2013) 55.